SABS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SABS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
SAB Biotherapeutics has the Momentum Rank of 0.
For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.
Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.
For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Thank you for viewing the detailed overview of SAB Biotherapeutics's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Eddie Joe Sullivan | director, 10 percent owner, officer: Chief Executive Officer | 2100 E 54TH STREET NORTH, SIOUX FALLS SD 57104 |
Michael King | officer: CHIEF FINANCIAL OFFICER | 2100 EAST 54TH STREET NORTH, SIOUX FALLS SD 57104 |
Samuel J Reich | director, officer: Executive Chairman | ACUITY PHARMACEUTICALS INC, 3701 MARKET STREET, PHILADELPHIA PA 19104 |
Sessa Capital Im, L.p. | director | 888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK NY 10019 |
Andrew Moin | director | 2100 EAST 54TH STREET NORTH, SIOUX FALLS SD 57104 |
Sessa Capital (master), L.p. | director | 888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK NY 10019 |
Sessa Capital Im Gp, Llc | director | 888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK NY 10019 |
John Petry | director | 888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK NY 10019 |
Sessa Capital Gp, Llc | director | 888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK NY 10019 |
Erick Lucera | director | 138 THISTLE ROAD, NORTH ANDOVER MA 08145 |
David Charles Link | director | 2100 E 54TH STREET NORTH, SIOUX FALLS SD 57104 |
Christine E Hamilton | director, 10 percent owner | 225 S MAIN AVE, P O BOX 5000, SIOUX FALLS SD 57117 |
Scott Giberson | director | 2100 EAST 54TH STREET NORTH, SIOUX FALLS SD 57104 |
Alexandra Kropotova | officer: Chief Medical Officer | RIVER OAKS TOWER, 8800 HSC PARKWAY, BYRAN TX 77807 |
Jeffrey G Spragens | director | 4400 BISCAYNE BOULEVARD, SUITE 1500, MIAMI FL 33137 |
From GuruFocus
By Value_Insider Value_Insider • 11-08-2022
By Marketwired • 10-05-2023
By Marketwired • 06-21-2023
By sperokesalga sperokesalga • 04-13-2023
By sperokesalga sperokesalga • 06-21-2023
By Marketwired • 10-02-2023
By sperokesalga sperokesalga • 05-16-2023
By sperokesalga sperokesalga • 05-04-2023
By Marketwired • 08-21-2023
By Value_Insider Value_Insider • 11-15-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.